Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
3(14%)
Results Posted
54%(7 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_1
3
14%
Ph not_applicable
8
36%
Ph phase_4
2
9%
Ph phase_2
4
18%
Ph phase_3
5
23%

Phase Distribution

3

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution22 total trials
Phase 1Safety & dosage
3(13.6%)
Phase 2Efficacy & side effects
4(18.2%)
Phase 3Large-scale testing
5(22.7%)
Phase 4Post-market surveillance
2(9.1%)
N/ANon-phased studies
8(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

13 of 16 finished

Non-Completion Rate

18.8%

3 ended early

Currently Active

3

trials recruiting

Total Trials

22

all time

Status Distribution
Active(5)
Completed(13)
Terminated(3)
Other(1)

Detailed Status

Completed13
Active, not recruiting3
Terminated2
Not yet recruiting1
Suspended1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
3
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (13.6%)
Phase 24 (18.2%)
Phase 35 (22.7%)
Phase 42 (9.1%)
N/A8 (36.4%)

Trials by Status

completed1359%
not_yet_recruiting15%
suspended15%
enrolling_by_invitation15%
terminated29%
withdrawn15%
active_not_recruiting314%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07371416Not Applicable

Regenerative Root Canal Treatment of Immature Teeth Using Omega-3 Fatty Acids

Active Not Recruiting
NCT02295059Not Applicable

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention

Active Not Recruiting
NCT07036952Not Applicable

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Enrolling By Invitation
NCT06918080Phase 4

Hepatoprotective Measures for Children at High Risk of NAFLD

Active Not Recruiting
NCT06627114Not Applicable

Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients

Not Yet Recruiting
NCT03784963Phase 1

Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD

Terminated
NCT00467818Not Applicable

Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

Completed
NCT04281121Not Applicable

Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver

Completed
NCT03280615Phase 3

Omega 3 Fatty Acids in Patients With Chronic Renal Disease

Completed
NCT01745263Phase 3

DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial

Completed
NCT01381354Phase 1

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Completed
NCT00962598Phase 2

The Role Of Omega-3 Fatty Acids In Adolescent Depression

Completed
NCT01803711Phase 2

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Terminated
NCT03079635Not Applicable

Breakfast and Energy Expenditure in Young Women

Completed
NCT00970489Phase 3

Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation

Completed
NCT02103517Phase 3

Fish Oil and Cardiovascular Suboptimal Health

Completed
NCT00508248Not Applicable

Omega 3 Fatty Acids and Atrial Fibrillation

Withdrawn
NCT00620672Phase 1

N-3 Fatty Acid Requirements for Human Development

Completed
NCT02764879Phase 2

Effect of Omega 3 on Periodontitis in Postmenopausal Women

Completed
NCT02041520Phase 3

Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive Patients

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22